Status: Not yet recruiting

Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 Tablet

This study is a single-center, single-sequence, self-controlled, open design, aiming to investigate the effects of rifampicin and clarithromycin on the pharmacokinetics of RSS0343 in humans.

Participants needed: 40

Trial details

Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Reistone Biopharma Company LimitedUpdated: Jul 10, 2026Locations: 1

Eligibility criteria

The participants voluntarily signed the informed consent form, fully understandi... [+3]

Those who smoked more than 5 cigarettes per day in the previous 3 months (or use... [+12]

Status: Recruiting

A Study to Evaluate the Efficacy and Safety of RSS0343 Tablets in Patients With Chronic Obstructive Pulmonary Disease

This study is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy and safety of RSS0343 tablets in patients with COPD. The study includes 3 study periods: a 4-week screening period, a 48-week treatment period, and a 4-week follow-up period. The primary endpoint is the annualized rate of moderate or severe exacerbations of COPD during the 48-week treatment period.

Participants needed: 300

Trial details

Phase: Phase 2Age: 40-80Biological sex: AllType: InterventionalSponsor: Reistone Biopharma Company LimitedUpdated: Jun 5, 2026Locations: 1

Eligibility criteria

Voluntarily sign a written informed consent form. [+9]

Subjects with systemic immunosuppressants, biologic agents, or Th2 cytokine inhi... [+21]

Status: Not yet recruiting

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.

Phase III Efficacy and Safety Study of RSS0393 Ointment in Plaque Psoriasis.

Participants needed: 600

Trial details

Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Reistone Biopharma Company LimitedUpdated: Apr 21, 2026Locations: 1

Eligibility criteria

Age must be ≥18 years on the day of signing the informed consent form, male or f... [+3]

Hemoglobin <100.0 g/L (for males) or <90.0 g/L (for females); [+13]

Clinical trials

Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 Tablet

A Study to Evaluate the Efficacy and Safety of RSS0343 Tablets in Patients With Chronic Obstructive Pulmonary Disease

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.